Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
GE-148-002: A Phase 2 Open-label Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer

Background: - GE-148 (18F) is a new drug that is designed to attach to prostate cancer cells. Researchers are interested in combining the drug with a small amount of radioactive material to allow prostate cancer lesions to appear more clearly on imaging scans. Researchers are also interested in determining whether …

National Institutes of Health Clinical Center, 9000 Rockville Pike
 (9.7 away) Contact site
  • 36 views
  • 08 Nov, 2020
  • 1 location
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Background Prostate cancer is a common cancer among men. There are several ways to treat it, including hormone blocking drugs, radiation therapy, and surgery. Researchers want to combine abiraterone and enzalutamide to see if there is a better way to treat prostate cancer. They also want to study a new …

National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 16 views
  • 20 Aug, 2020
  • 1 location
A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism

The goal of the study is to evaluate the efficacy and safety of crizanlizumab in SCD patients with priapism.

Children s National Hospital SC
 (5.3 away) Contact site
  • 23 views
  • 28 Oct, 2020
  • +16 other locations
Radium-223 in Biochemically Recurrent Prostate Cancer

Background Some men who have been treated for localized prostate cancer with surgery or radiation still show signs of the disease in their blood. This is called biochemically recurrent prostate cancer. Radium-223 is a small molecule. It uses radiation to kill cancer cells and improves survival in advanced prostate cancer. …

National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 0 views
  • 02 Dec, 2020
  • 1 location
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary …

abiraterone
androgen suppression
prednisone
androgens
antiandrogen therapy
Site US10050
 (7.0 away) Contact site
  • 1404 views
  • 02 Dec, 2020
  • +130 other locations
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Background Prostate cancer is the second leading cause of cancer deaths in American men. When prostate cancer is confined to the prostate there is a high chance of cure. However, it is outside the prostate or comes back after treatment, additional therapy may be needed. Current methods of imaging prostate …

adenocarcinoma
cancer
adenocarcinoma of prostate
pet/ct scan
recurrent prostate cancer
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 122 views
  • 16 Sep, 2020
  • 1 location
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Background Prostate cancer is the second leading cause of cancer deaths in American men. Few options exist to create images of this type of cancer. Researchers think an experimental radiotracer called 18F-DCFPyL could find sites of cancer in the body. Objective To see if 18F-DCFPyL can identify sites of prostate …

positron emission tomography
metastasis
prostate cancer metastatic
metastatic prostate cancer
pet/ct scan
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 2 views
  • 16 Sep, 2020
  • 1 location
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Background Some people with prostate cancer have a rise in prostate-specific antigen (PSA). This can happen even after treatments like radiation and surgery. Androgen deprivation therapy (ADT) drugs and close monitoring are one standard way to treat this group of people. Another way is to monitor people and their PSA …

androgens
nilutamide
recurrent prostate cancer
ct scan
progressive disease
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 56 views
  • 14 Oct, 2020
  • 1 location
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

This randomized phase II trial studies how well abiraterone acetate and antiandrogen therapy, with or without cabazitaxel and prednisone, work in treating patients with castration-resistant prostate cancer previously treated with docetaxel that has spread to other parts of the body. Androgens can cause the growth of prostate cancer cells. Hormone …

adenocarcinoma
androgens
lhrh analogue
nilutamide
measurable disease
Sibley Memorial Hospital
 (8.2 away) Contact site
  • 1518 views
  • 27 May, 2020
  • +440 other locations
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

The purpose of this study is to test the effectiveness of the experimental drug, 177Lu-J591 in combination with ketoconazole and hydrocortisone against prostate cancer.

metastasis
adenocarcinoma
surgical castration
diphosphonates
testosterone
Georgetown University Medical Center
 (7.9 away) Contact site
  • 139 views
  • 02 Mar, 2020
  • +13 other locations